nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Carboplatin—bone cancer	0.47	0.539	CbGbCtD
Cefdinir—MPO—Cisplatin—bone cancer	0.402	0.461	CbGbCtD
Cefdinir—Skin candida—Epirubicin—bone cancer	0.00611	0.0478	CcSEcCtD
Cefdinir—Skin candida—Doxorubicin—bone cancer	0.00565	0.0442	CcSEcCtD
Cefdinir—Hepatitis acute—Methotrexate—bone cancer	0.00518	0.0405	CcSEcCtD
Cefdinir—Amylase increased—Cisplatin—bone cancer	0.00288	0.0225	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Epirubicin—bone cancer	0.00279	0.0218	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Doxorubicin—bone cancer	0.00258	0.0202	CcSEcCtD
Cefdinir—Nephropathy toxic—Cisplatin—bone cancer	0.00239	0.0187	CcSEcCtD
Cefdinir—Allergic cutaneous angiitis—Methotrexate—bone cancer	0.00237	0.0185	CcSEcCtD
Cefdinir—Erythema nodosum—Epirubicin—bone cancer	0.00163	0.0127	CcSEcCtD
Cefdinir—Nephropathy—Methotrexate—bone cancer	0.00158	0.0124	CcSEcCtD
Cefdinir—Interstitial pneumonia—Methotrexate—bone cancer	0.00156	0.0122	CcSEcCtD
Cefdinir—Leukocytoclastic vasculitis—Methotrexate—bone cancer	0.00153	0.012	CcSEcCtD
Cefdinir—Erythema nodosum—Doxorubicin—bone cancer	0.00151	0.0118	CcSEcCtD
Cefdinir—Leukorrhea—Epirubicin—bone cancer	0.0015	0.0117	CcSEcCtD
Cefdinir—Vaginal moniliasis—Epirubicin—bone cancer	0.0014	0.0109	CcSEcCtD
Cefdinir—Leukorrhea—Doxorubicin—bone cancer	0.00139	0.0109	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Epirubicin—bone cancer	0.00134	0.0105	CcSEcCtD
Cefdinir—Body temperature increased—Carboplatin—bone cancer	0.00132	0.0103	CcSEcCtD
Cefdinir—Vaginal moniliasis—Doxorubicin—bone cancer	0.00129	0.0101	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Epirubicin—bone cancer	0.00129	0.0101	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Doxorubicin—bone cancer	0.00124	0.00969	CcSEcCtD
Cefdinir—Vaginal discharge—Methotrexate—bone cancer	0.00124	0.00967	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Doxorubicin—bone cancer	0.00119	0.00932	CcSEcCtD
Cefdinir—Vaginal discharge—Epirubicin—bone cancer	0.00116	0.00905	CcSEcCtD
Cefdinir—Haemolytic anaemia—Cisplatin—bone cancer	0.0011	0.00862	CcSEcCtD
Cefdinir—Renal failure acute—Cisplatin—bone cancer	0.00108	0.00843	CcSEcCtD
Cefdinir—Vaginal discharge—Doxorubicin—bone cancer	0.00107	0.00837	CcSEcCtD
Cefdinir—Interstitial lung disease—Methotrexate—bone cancer	0.00106	0.00831	CcSEcCtD
Cefdinir—Ileus—Epirubicin—bone cancer	0.000995	0.00778	CcSEcCtD
Cefdinir—Ileus—Doxorubicin—bone cancer	0.00092	0.0072	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000896	0.00701	CcSEcCtD
Cefdinir—Pancytopenia—Cisplatin—bone cancer	0.000817	0.00639	CcSEcCtD
Cefdinir—Acute coronary syndrome—Cisplatin—bone cancer	0.000756	0.00591	CcSEcCtD
Cefdinir—Renal failure—Cisplatin—bone cancer	0.000754	0.0059	CcSEcCtD
Cefdinir—Vaginal inflammation—Methotrexate—bone cancer	0.000752	0.00588	CcSEcCtD
Cefdinir—Myocardial infarction—Cisplatin—bone cancer	0.000752	0.00588	CcSEcCtD
Cefdinir—Dyskinesia—Epirubicin—bone cancer	0.000749	0.00586	CcSEcCtD
Cefdinir—Stomatitis—Cisplatin—bone cancer	0.000748	0.00585	CcSEcCtD
Cefdinir—Conjunctivitis—Cisplatin—bone cancer	0.000745	0.00583	CcSEcCtD
Cefdinir—Melaena—Methotrexate—bone cancer	0.000735	0.00575	CcSEcCtD
Cefdinir—Vaginal infection—Methotrexate—bone cancer	0.00071	0.00555	CcSEcCtD
Cefdinir—Aplastic anaemia—Methotrexate—bone cancer	0.000706	0.00552	CcSEcCtD
Cefdinir—Vaginal inflammation—Epirubicin—bone cancer	0.000704	0.00551	CcSEcCtD
Cefdinir—Dyskinesia—Doxorubicin—bone cancer	0.000693	0.00542	CcSEcCtD
Cefdinir—Melaena—Epirubicin—bone cancer	0.000688	0.00538	CcSEcCtD
Cefdinir—Candida infection—Epirubicin—bone cancer	0.000672	0.00526	CcSEcCtD
Cefdinir—Vaginal infection—Epirubicin—bone cancer	0.000665	0.0052	CcSEcCtD
Cefdinir—Aplastic anaemia—Epirubicin—bone cancer	0.000661	0.00517	CcSEcCtD
Cefdinir—Vaginal inflammation—Doxorubicin—bone cancer	0.000651	0.00509	CcSEcCtD
Cefdinir—Rash maculo-papular—Epirubicin—bone cancer	0.00064	0.005	CcSEcCtD
Cefdinir—Melaena—Doxorubicin—bone cancer	0.000636	0.00498	CcSEcCtD
Cefdinir—Candida infection—Doxorubicin—bone cancer	0.000622	0.00486	CcSEcCtD
Cefdinir—Vaginal infection—Doxorubicin—bone cancer	0.000615	0.00481	CcSEcCtD
Cefdinir—Aplastic anaemia—Doxorubicin—bone cancer	0.000612	0.00478	CcSEcCtD
Cefdinir—Hepatic failure—Methotrexate—bone cancer	0.000608	0.00475	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—bone cancer	0.000592	0.00463	CcSEcCtD
Cefdinir—Renal failure acute—Methotrexate—bone cancer	0.000591	0.00463	CcSEcCtD
Cefdinir—Flatulence—Cisplatin—bone cancer	0.000591	0.00462	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—bone cancer	0.000585	0.00457	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Methotrexate—bone cancer	0.000579	0.00453	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—bone cancer	0.000569	0.00445	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—bone cancer	0.000554	0.00433	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—bone cancer	0.000542	0.00424	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—bone cancer	0.000541	0.00423	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—bone cancer	0.000537	0.0042	CcSEcCtD
Cefdinir—Leukopenia—Cisplatin—bone cancer	0.000536	0.0042	CcSEcCtD
Cefdinir—Purpura—Epirubicin—bone cancer	0.00053	0.00415	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—bone cancer	0.000526	0.00411	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—bone cancer	0.000524	0.0041	CcSEcCtD
Cefdinir—Convulsion—Cisplatin—bone cancer	0.000519	0.00406	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—bone cancer	0.000512	0.00401	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000501	0.00392	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—bone cancer	0.000497	0.00389	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000492	0.00385	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—bone cancer	0.000491	0.00384	CcSEcCtD
Cefdinir—Anaphylactic shock—Cisplatin—bone cancer	0.000489	0.00382	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—bone cancer	0.000485	0.00379	CcSEcCtD
Cefdinir—Thrombocytopenia—Cisplatin—bone cancer	0.000479	0.00375	CcSEcCtD
Cefdinir—Asthma—Methotrexate—bone cancer	0.000472	0.00369	CcSEcCtD
Cefdinir—Anorexia—Cisplatin—bone cancer	0.000466	0.00365	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00046	0.0036	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00046	0.0036	CcSEcCtD
Cefdinir—Pancytopenia—Methotrexate—bone cancer	0.000448	0.00351	CcSEcCtD
Cefdinir—Asthma—Epirubicin—bone cancer	0.000442	0.00345	CcSEcCtD
Cefdinir—Neutropenia—Methotrexate—bone cancer	0.000441	0.00345	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000426	0.00333	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000426	0.00333	CcSEcCtD
Cefdinir—Decreased appetite—Cisplatin—bone cancer	0.000425	0.00332	CcSEcCtD
Cefdinir—Pneumonia—Methotrexate—bone cancer	0.000423	0.00331	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Cisplatin—bone cancer	0.000422	0.0033	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—bone cancer	0.000419	0.00328	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000417	0.00326	CcSEcCtD
Cefdinir—Renal failure—Methotrexate—bone cancer	0.000414	0.00324	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—bone cancer	0.000413	0.00323	CcSEcCtD
Cefdinir—Stomatitis—Methotrexate—bone cancer	0.00041	0.00321	CcSEcCtD
Cefdinir—Conjunctivitis—Methotrexate—bone cancer	0.000409	0.0032	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—bone cancer	0.000409	0.0032	CcSEcCtD
Cefdinir—Haematuria—Methotrexate—bone cancer	0.000401	0.00314	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—bone cancer	0.000396	0.0031	CcSEcCtD
Cefdinir—Agranulocytosis—Methotrexate—bone cancer	0.000393	0.00307	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00039	0.00305	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—bone cancer	0.000388	0.00304	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—bone cancer	0.000387	0.00303	CcSEcCtD
Cefdinir—Body temperature increased—Cisplatin—bone cancer	0.000387	0.00302	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—bone cancer	0.000384	0.003	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—bone cancer	0.000384	0.003	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—bone cancer	0.000383	0.00299	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—bone cancer	0.000382	0.00299	CcSEcCtD
Cefdinir—Haemoglobin—Methotrexate—bone cancer	0.00038	0.00297	CcSEcCtD
Cefdinir—Haemorrhage—Methotrexate—bone cancer	0.000378	0.00295	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—bone cancer	0.000375	0.00294	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—bone cancer	0.000368	0.00287	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—bone cancer	0.000367	0.00287	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000361	0.00283	CcSEcCtD
Cefdinir—Hypersensitivity—Cisplatin—bone cancer	0.00036	0.00282	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—bone cancer	0.000358	0.0028	CcSEcCtD
Cefdinir—Erythema multiforme—Methotrexate—bone cancer	0.000357	0.00279	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—bone cancer	0.000355	0.00278	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—bone cancer	0.000355	0.00278	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—bone cancer	0.000355	0.00278	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—bone cancer	0.000354	0.00277	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—bone cancer	0.000354	0.00276	CcSEcCtD
Cefdinir—Asthenia—Cisplatin—bone cancer	0.000351	0.00274	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—bone cancer	0.000347	0.00272	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—bone cancer	0.00034	0.00266	CcSEcCtD
Cefdinir—Diarrhoea—Cisplatin—bone cancer	0.000335	0.00262	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—bone cancer	0.000334	0.00261	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—bone cancer	0.000329	0.00257	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—bone cancer	0.000327	0.00256	CcSEcCtD
Cefdinir—Vomiting—Cisplatin—bone cancer	0.000311	0.00243	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—bone cancer	0.000309	0.00242	CcSEcCtD
Cefdinir—Rash—Cisplatin—bone cancer	0.000308	0.00241	CcSEcCtD
Cefdinir—Dermatitis—Cisplatin—bone cancer	0.000308	0.00241	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—bone cancer	0.000303	0.00237	CcSEcCtD
Cefdinir—Leukopenia—Methotrexate—bone cancer	0.000294	0.0023	CcSEcCtD
Cefdinir—Nausea—Cisplatin—bone cancer	0.000291	0.00227	CcSEcCtD
Cefdinir—Convulsion—Methotrexate—bone cancer	0.000285	0.00223	CcSEcCtD
Cefdinir—Agitation—Epirubicin—bone cancer	0.000283	0.00221	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—bone cancer	0.000281	0.00219	CcSEcCtD
Cefdinir—Chest pain—Methotrexate—bone cancer	0.00028	0.00219	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—bone cancer	0.000275	0.00215	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—bone cancer	0.00027	0.00212	CcSEcCtD
Cefdinir—Anaphylactic shock—Methotrexate—bone cancer	0.000268	0.0021	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—bone cancer	0.000267	0.00209	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—bone cancer	0.000266	0.00208	CcSEcCtD
Cefdinir—Thrombocytopenia—Methotrexate—bone cancer	0.000263	0.00206	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—bone cancer	0.000262	0.00205	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—bone cancer	0.000262	0.00205	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—bone cancer	0.000256	0.002	CcSEcCtD
Cefdinir—Anorexia—Methotrexate—bone cancer	0.000256	0.002	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—bone cancer	0.000255	0.00199	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—bone cancer	0.000251	0.00196	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—bone cancer	0.00025	0.00196	CcSEcCtD
Cefdinir—Shock—Epirubicin—bone cancer	0.000247	0.00193	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—bone cancer	0.000247	0.00193	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—bone cancer	0.000246	0.00192	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—bone cancer	0.000246	0.00192	CcSEcCtD
Cefdinir—Insomnia—Methotrexate—bone cancer	0.000243	0.0019	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—bone cancer	0.000242	0.0019	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—bone cancer	0.000239	0.00187	CcSEcCtD
Cefdinir—Somnolence—Methotrexate—bone cancer	0.000239	0.00187	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—bone cancer	0.000237	0.00185	CcSEcCtD
Cefdinir—Dyspepsia—Methotrexate—bone cancer	0.000236	0.00185	CcSEcCtD
Cefdinir—Decreased appetite—Methotrexate—bone cancer	0.000233	0.00182	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—bone cancer	0.000232	0.00182	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Methotrexate—bone cancer	0.000232	0.00181	CcSEcCtD
Cefdinir—Shock—Doxorubicin—bone cancer	0.000229	0.00179	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—bone cancer	0.000228	0.00178	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—bone cancer	0.000227	0.00178	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—bone cancer	0.000223	0.00175	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—bone cancer	0.000222	0.00173	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—bone cancer	0.000221	0.00173	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methotrexate—bone cancer	0.000219	0.00172	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—bone cancer	0.000218	0.00171	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—bone cancer	0.000217	0.0017	CcSEcCtD
Cefdinir—Constipation—Epirubicin—bone cancer	0.000215	0.00168	CcSEcCtD
Cefdinir—Body temperature increased—Methotrexate—bone cancer	0.000212	0.00166	CcSEcCtD
Cefdinir—Abdominal pain—Methotrexate—bone cancer	0.000212	0.00166	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—bone cancer	0.00021	0.00164	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—bone cancer	0.000207	0.00162	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—bone cancer	0.000205	0.00161	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—bone cancer	0.000205	0.0016	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—bone cancer	0.000202	0.00158	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000201	0.00157	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—bone cancer	0.000199	0.00155	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—bone cancer	0.000199	0.00155	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—bone cancer	0.000199	0.00155	CcSEcCtD
Cefdinir—Hypersensitivity—Methotrexate—bone cancer	0.000198	0.00155	CcSEcCtD
Cefdinir—Asthenia—Methotrexate—bone cancer	0.000193	0.00151	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00019	0.00149	CcSEcCtD
Cefdinir—Pruritus—Methotrexate—bone cancer	0.00019	0.00148	CcSEcCtD
Cefdinir—Hypersensitivity—Epirubicin—bone cancer	0.000185	0.00145	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—bone cancer	0.000184	0.00144	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—bone cancer	0.000184	0.00144	CcSEcCtD
Cefdinir—Diarrhoea—Methotrexate—bone cancer	0.000184	0.00144	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—bone cancer	0.00018	0.00141	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—bone cancer	0.000178	0.00139	CcSEcCtD
Cefdinir—Dizziness—Methotrexate—bone cancer	0.000177	0.00139	CcSEcCtD
Cefdinir—Diarrhoea—Epirubicin—bone cancer	0.000172	0.00134	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—bone cancer	0.000171	0.00134	CcSEcCtD
Cefdinir—Vomiting—Methotrexate—bone cancer	0.000171	0.00133	CcSEcCtD
Cefdinir—Rash—Methotrexate—bone cancer	0.000169	0.00132	CcSEcCtD
Cefdinir—Dermatitis—Methotrexate—bone cancer	0.000169	0.00132	CcSEcCtD
Cefdinir—Headache—Methotrexate—bone cancer	0.000168	0.00131	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—bone cancer	0.000167	0.0013	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—bone cancer	0.000166	0.0013	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—bone cancer	0.000164	0.00129	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—bone cancer	0.00016	0.00125	CcSEcCtD
Cefdinir—Nausea—Methotrexate—bone cancer	0.000159	0.00125	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—bone cancer	0.000159	0.00124	CcSEcCtD
Cefdinir—Rash—Epirubicin—bone cancer	0.000158	0.00124	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—bone cancer	0.000158	0.00124	CcSEcCtD
Cefdinir—Headache—Epirubicin—bone cancer	0.000157	0.00123	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—bone cancer	0.000154	0.0012	CcSEcCtD
Cefdinir—Nausea—Epirubicin—bone cancer	0.000149	0.00117	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—bone cancer	0.000148	0.00116	CcSEcCtD
Cefdinir—Rash—Doxorubicin—bone cancer	0.000147	0.00115	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—bone cancer	0.000146	0.00114	CcSEcCtD
Cefdinir—Headache—Doxorubicin—bone cancer	0.000146	0.00114	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—bone cancer	0.000138	0.00108	CcSEcCtD
